Literature DB >> 12360495

A family with gastrointestinal amyloidosis associated with variant lysozyme.

Brigitte Granel1, Jacques Serratrice, Sophie Valleix, Gilles Grateau, Dominique Droz, Jacques Lafon, Marie-Christine Sault, Bernard Chaudier, Patrick Disdier, René Laugier, Marc Delpech, Pierre-Jean Weiller.   

Abstract

Hereditary nonneuropathic systemic lysozyme amyloidosis is a very rare form of amyloidosis, and only 4 families with this condition have been detailed until now in the literature. Clinical manifestations of lysozyme amyloidosis observed until now mainly concerned the kidneys, liver, and digestive tract. We report here a new family with hereditary lysozyme amyloidosis who presented predominantly with gastrointestinal involvement. The proband, a middle-aged woman, underwent partial gastrectomy for a hemorrhagic "gastric peptic ulcer" in 1984. Gastrointestinal amyloidosis was diagnosed in 1998 on biopsies performed on the gastroduodenal anastomosis, which appeared to be very congestive at presentation. Immunohistochemical stainings in tissue sections were positive for lysozyme. Amyloid was also observed in the colonic mucosa. The patient had a mutation in the lysozyme gene characterized by substitution of the amino acid at position 64 in the mature protein from tryptophan to arginine, previously described in only 1 French family with prominent nephropathy. It is interesting to note that her father had died many years before with an uncharacterized digestive amyloidosis. Our observation shows that a search for gastrointestinal amyloidosis is important, particularly when physicians are faced with congestive mucosa, unexplained abdominal hemorrhage, or abdominal symptoms. When gastrointestinal amyloidosis is diagnosed, it is important to determine with precision the nature of the amyloid fibril proteins, because various types of amyloidosis can involve the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12360495     DOI: 10.1053/gast.2002.36022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.

Authors:  Christine L Hagan; Russell J K Johnson; Anne Dhulesia; Mireille Dumoulin; Janice Dumont; Erwin De Genst; John Christodoulou; Carol V Robinson; Christopher M Dobson; Janet R Kumita
Journal:  Protein Eng Des Sel       Date:  2010-04-09       Impact factor: 1.650

Review 2.  Hereditary lysozyme amyloidosis with sicca syndrome, digestive, arterial, and tracheobronchial involvement: case-based review.

Authors:  Audrey Benyamine; Fanny Bernard-Guervilly; Céline Tummino; Nicolas Macagno; Laurent Daniel; Sophie Valleix; Brigitte Granel
Journal:  Clin Rheumatol       Date:  2017-09-30       Impact factor: 2.980

3.  In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme.

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  BMC Struct Biol       Date:  2018-07-20

Review 4.  Hereditary renal amyloidosis with a variant lysozyme p.Trp82Arg in a Chinese family: case report and literature review.

Authors:  Zhenyu Li; Hui Xu; Dan Liu; Danyang Li; Gang Liu; Su-Xia Wang
Journal:  BMC Nephrol       Date:  2019-08-08       Impact factor: 2.388

5.  A new family with hereditary lysozyme amyloidosis with gastritis and inflammatory bowel disease as prevailing symptoms.

Authors:  Estelle Jean; Mikael Ebbo; Sophie Valleix; Lucas Benarous; Laurent Heyries; Aurélie Grados; Emmanuelle Bernit; Gilles Grateau; Thomas Papo; Brigitte Granel; Laurent Daniel; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  BMC Gastroenterol       Date:  2014-09-13       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.